Skip to main content
SpringerLink
Log in

Xingnaojing Combined with Brain Glycoside Peptide Targets LncRNA-H19 and Regulates hsa-microRNA (miR)-138-5p/MAPK6 to Alleviate Acute Ischemic Stroke

  • CLINICAL NEUROCHEMISTRY
  • Published:
Neurochemical Journal Aims and scope Submit manuscript

Abstract

This study aimed to explore the efficacy of Xingnaojing combined with brain glycoside peptide (XCGP) in the treatment and prognosis of acute ischemic stroke (AIS). The expression levels of long non-coding RNA (lncRNA)-H19 and mitogen-activated protein kinase 6 (MAPK6) in 37 AIS patients were measured using quantitative reverse transcription polymerase chain reaction (RT-qPCR). The correlation between lncRNA-H19, microRNA (miR)-138-5p and MAPK6 was predicted using StarBase online software. In vitro and in vivo experiments were carried out using the ReNcell CX neural stem cell (NSC) line and an AIS rat model constructed by middle cerebral artery occlusion surgery, respectively. Following human ReNcell CX cell culture in a hypoxic environment, RT-qPCR was conducted to measure the expression levels of the related genes, MTT and WST-1 assays were performed to assess the proliferation and viability of ReNcell CX NSCs, and flow cytometry was utilized to assess ReNcell CX NSC apoptosis. In addition, the rotarod, beam walk, and adhesion removal tests were conducted to evaluate changes in the motility of rats with AIS, and the infarction volume was calculated. The results of RT-qPCR showed that lncRNA-H19 and MAPK6 were upregulated in AIS patients. The StarBase online software for the prediction of miRNA-target interactions showed that lncRNA-H19 targets miR-138-5p, which targets MAPK6 (P < 0.01 and P < 0.001, respectively). Further, human ReNcell CX cells that were administered XCGP displayed marked downregulation of MAPK6, and the AIS rat model with XCGP injection showed effective reduction in infarction volume, and notable recovery of motility (P < 0.01 and P < 0.001). XCGP may serve as a candidate for the treatment of AIS, thereby improving the ischemic status of ReNcell CX NSCs and the condition of rats with AIS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.

Similar content being viewed by others

REFERENCES

  1. Arnold, M., Halpern, M., Meier, N., Fischer, U., Haefeli, T., Kappeler, L., Brekenfeld, C., Mattle, H.P., and Nedeltchev, K., J. Neurol., 2008, vol. 255, no. 10, pp. 1503–1507.

    Article  CAS  PubMed  Google Scholar 

  2. Yang, X., Wang, L., Zheng, L., Wu, J., Liu, J., Hao, Z., Zhang, S., Wu, B., Liu, M., and Wang, D., Curr. Neurovasc. Res., 2020, vol. 17, no. pp. 385–393.

  3. Ye, C., Wang, Y., Song, Q., Liu, J., Wei, C., and Liu, M., Curr. Neurovasc. Res., 2020, vol. 17, no. pp. 344–353.

  4. Waqas, M., Rai, A.T., Vakharia, K., Chin, F., and Siddiqui, A.H., J. Neurointerv. Surg., 2020, vol. 12, no. 3, pp. 260–265.

    Article  PubMed  Google Scholar 

  5. Lakomkin, N., Dhamoon, M., Carroll, K., Singh, I.P., Tuhrim, S., Lee, J., Fifi, J.T., and Mocco, J., J. Neurointerv. Surg., 2019, vol. 11, no. 3, pp. 241–245.

    Article  PubMed  Google Scholar 

  6. Hu, S., Zheng, J., Du, Z., and Wu, G., Brain Res., 2020, vol. 1732, no. pp. 146681.

  7. Li, P., Hu, F., Cao, X., Luo, L., and Tu, Q., J. Recept. Signal Transduct. Res., 2020, vol. 40, no. 2, pp. 117–125.

    Article  PubMed  Google Scholar 

  8. Taha, S.H.N., Zaghloul, H.S., Ali, A., Gaballah, I.F., Rashed, L.A., and Aboulhoda, B.E., Naunyn Schmiedebergs Arch. Pharmacol., 2020, vol. 393, no. pp. 1635–1648.

  9. Qin, C., Xia, T., Li, G., Zou, Y., Cheng, Z., and Wang, Q., Int. J. Clin. Exp. Pathol., 2019, vol. 12, no. 9, pp. 3440–3446.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Guo, W., Ma, J., Yang, Y., Guo, S., Zhang, W., Zhao, T., Yi, X., Wang, H., Wang, S., Liu, Y., Dai, W., Chen, X., Shi, Q., Wang, G., Gao, T., and Li, C., Clin. Cancer Res., 2020, vol. 26, no. pp. 2725–2739.

  11. Yang, C., Luo, J., Luo, X., Jia, W., Fang, Z., Yi, S., and Li, L., Ann. Transl. Med., 2020, vol. 8, no. 6, pp. 327.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Liu, Z., Zhang, J., Zhang, F., and Chang, Y., Gene, 2020, vol. 741, no. pp. 144562.

  13. Yang, F., Qin, Y., Wang, Y., Li, A., Lv, J., Sun, X., Che, H., Han, T., Meng, S., Bai, Y., and Wang, L., Cell. Physiol. Biochem., 2018, vol. 50, no. 4, pp. 1230–1244.

    Article  CAS  PubMed  Google Scholar 

  14. Liu, C., Li, X., Hao, Y., Wang, F., Cheng, Z., Geng, H., and Geng, D., Aging, 2020, vol. 12, no. pp. 8680–8701.

  15. Yuan, B., Guan, Q., Yan, T., Zhang, X., Xu, W., and Li, J., Cancer Biother. Radiopharm., 2020, vol. 35, no. pp. 711–719.

  16. Deng, Q.W., Li, S., Wang, H., Sun, H.L., Zuo, L., Gu, Z.T., Lu, G., Sun, C.Z., Zhang, H.Q., and Yan, F.L., Clin. Sci., 2018, vol. 132, no. 14, pp. 1597–1614.

    Article  CAS  Google Scholar 

  17. Cao, H.J., Liang, S.B., Zhou, W., Wu, J.R., and Zhang, C.L., Medicine, 2019, vol. 98, no. 15, pp. e15181.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Xu, P., Du, S.Y., Lu, Y., Bai, J., Guo, Y.W., Du, Q., and Cao, Y.F., J. Ethnopharmacol., 2014, vol. 152, no. 2, pp. 302–307.

    Article  CAS  PubMed  Google Scholar 

  19. Chen, Y., Sun, Y., Li, W., Wei, H., Long, T., Li, H., Xu, Q., and Liu, W., J. Pharmacol. Sci., 2018, vol. 136, no. 1, pp. 16–25.

    Article  CAS  PubMed  Google Scholar 

  20. Hu, Z., Shi, Y., Niu, H., Cai, Y., Jiang, G., and Wu, Y., Environ. Toxicol. Chem., 2010, vol. 29, no. 9, pp. 1877–1882.

    Article  CAS  PubMed  Google Scholar 

  21. Wu, L., Zhang, H., Xing, Y., Gao, Y., Li, Y., Ren, X., Li, J., Nie, B., Zhu, L., Shang, H., and Gao, Y., Medicine, 2016, vol. 95, no. 7, pp. e2875.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Xin, H., Shi, Z., Wu, L., Zhang, M., Yuan, X., Wang, P., Xu, Y., Zeng, G., and Wang, H., Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2019, vol. 44, no. 12, pp. 1330–1337.

    PubMed  Google Scholar 

  23. Chen, X.T., Wang, X.G., Xie, L.Y., Huang, J.W., Zhao, W., Wang, Q., Yao, L.M., and Li, W.R., Biomed Res. Int., 2019, vol. 2019, no. pp. 2389485.

  24. Gao, Y., Hu, Y.Z., Li, R.S., Han, Z.T., Geng, Y., Xia, Z., Du, W.J., Liu, L.X., Zhang, H.H., and Wang, L.N., Neuropsychiatr. Dis. Treat., 2015, vol. 11, no. pp. 537–548.

  25. Livak, K.J., and Schmittgen, T.D., Methods, 2001, vol. 25, no. 4, pp. 402–408.

    Article  CAS  PubMed  Google Scholar 

  26. Wang, J., Cao, B., Han, D., Sun, M., and Feng, J., Aging Dis., 2017, vol. 8, no. 1, pp. 71–84.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Zhou, Y.H., Huang, Y.Y., and Ma, M., Eur. Rev. Med. Pharmacol. Sci., 2018, vol. 22, no. 17, pp. 5569–5575.

    PubMed  Google Scholar 

  28. Yang, J.H., Li, J.H., Shao, P., Zhou, H., Chen, Y.Q., and Qu, L.H., Nucleic Acids Res., 2011, vol. 39, no. Database issue, pp. D202–D209.

  29. Ranke, J., Molter, K., Stock, F., Bottin-Weber, U., Poczobutt, J., Hoffmann, J., Ondruschka, B., Filser, J., and Jastorff, B., Ecotoxicol. Environ. Saf., 2004, vol. 58, no. 3, pp. 396–404.

    Article  CAS  PubMed  Google Scholar 

  30. Li, W., Abdul, Y., and Ergul A., Methods Mol. Biol., 2023, vol. 2616, pp. 467–479.

    Article  PubMed  Google Scholar 

  31. Hawk, T., Zhang, Y.Q., Rajakumar, G., Day, A.L., and Simpkins, J.W., Brain Res., 1998, vol. 796, no. 1–2, pp. 296–298.

    Article  CAS  PubMed  Google Scholar 

  32. Belayev, L., Alonso, O.F., Busto, R., Zhao, W., and Ginsberg, M.D., Stroke, 1996, vol. 27, no. 9, pp. 1616-1622; discussion 1623.

    Article  CAS  PubMed  Google Scholar 

  33. Liang, B., Wang, S., Zhu, X.G., Yu, Y.X., Cui, Z.R., and Yu, Y.Z., World J. Gastroenterol., 2005, vol. 11, no. 5, pp. 623–628.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Al-Mahdi, R., Babteen, N., Thillai, K., Holt, M., Johansen, B., Wetting, H. L., Seternes, O.M., and Wells, C.M., Cell Adh. Migr., 2015, vol. 9, no. 6, pp. 483–494.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Zhu, R., Liu, X., and He, Z., Mol. Brain, 2018, vol. 11, no. 1, pp. 58.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Shaath, H., Toor, S.M., Nada, M.A., Elkord, E., and Alajez, N.M., Sci. Rep., 2021, vol. 11, no. 1, pp. 14456.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ou, L., Wang, D., Zhang, H., Yu, Q., and Hua, F., Oncol. Res., 2018, vol. 26, no. 3, pp. 401–410.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Tian, B., Zhao, J., Xie, X., Chen, T., Yin, Y., Zhai, R., Wang, X., An, W., and Li, J., Food Funct., 2021, vol. 12, no. 9, pp. 3855–3871.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No external funding was received.

Author information

Authors and Affiliations

  1. Intensive Care Unit, the 5th People’s Hospital of Jinan, 250022, Jinan, Shandong, China

    J. Xu, M. M. Zhang, Q. Zhou & W. Liu

Authors
  1. J. Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. M. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Q. Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Liu.

Ethics declarations

Conflict of interest. The authors declare that they have no conflicts of interest.

Ethical approval. This study was reviewed and approved by the Ethical Board of the 5th People’s Hospital of Jinan (no.: ChiCTR18000155682). All operations were approved by the Animal Use and Care Committee of the 5th People’s Hospital of Jinan.

Informed consent. Informed consent was obtained from all individual participants included in the study.

Additional information

Corresponding author; address: Intensive Care Unit, The 5th People’s Hospital of Jinan, No. 24297, Jingshi Road, Jinan, Shandong, 250022 China; e-mail: liuwei065@163.com.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, J., Zhang, M.M., Zhou, Q. et al. Xingnaojing Combined with Brain Glycoside Peptide Targets LncRNA-H19 and Regulates hsa-microRNA (miR)-138-5p/MAPK6 to Alleviate Acute Ischemic Stroke. Neurochem. J. 17, 492–501 (2023). https://doi.org/10.1134/S1819712423030182

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1819712423030182

Keywords:

Search

Navigation